BioStat Solutions, Inc. (BSSI) is a statistical consulting corporation in service to the pharmaceutical, biotechnology and biodefense industries, specializing in Biomarker Statistics, Medical Countermeasures, and Medical Devices. In the area of Biomarker Statistics, we have successful collaborations with 7 of the top 15 pharma companies as well as numerous mid-size pharma and biotech companies. Our team has extensive experience in biomarker analysis in Phase I-III clinical trials, post-marketing studies and non-clinical studies across therapeutic areas. We are adept at analyzing data from a range of assay platforms, including gene expression, SNP genotyping, sequencing, protein immunoassays, IHC and copy number variation.
Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrated approach to cancer treatment. CTCA serves patients with complex cancer at facilities located suburban Atlanta, Chicago, Philadelphia, suburban Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowered Care®, CTCA provides patients with information about cancer and their treatment options, so they can control their treatment decisions. For more information about CTCA, go to www.cancercenter.com.
BIOBASE is a leading provider of manually-curated databases for molecular diagnostics. The Human Gene Mutation Database (HGMD®), Genome Trax™ for variant analysis, and The PharmacoGenomic Mutation Database (PGMD™), offer well-structured data, assembled by qualified experts, organized in an easily searchable manner that enables researchers to make clinical interpretations of data arising from next-generation sequencing efforts.
Life Technologies Corporation is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions are secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Fenwick & West LLP provides comprehensive legal services to technology and life sciences clients of national and international prominence.
Tiatros moves the workflow processes to coordinate healthcare to a secure mobile cloud, where everyone involved has access to the necessary information and people, smoothing out clinical workflows and adding a social layer to improve healthcare efficiency. Website: www.tiatros.com
CRL is a privately held CLIA and CAP certified reference laboratory offering leading edge testing services in the areas of Molecular Diagnostics, Clinical Trials, Wellness, Toxicology, and Insurance. CRL has grown over the past 35 years to be the largest privately-held single-site laboratory in the country. CRL currently performs over 100 million tests annually for hundreds of clients. CRL is committed to treating each and every sample as a life entrusted to their care. As CRL recognizes the expanding applications of molecular diagnostics, they are committed to being a flexible, responsive laboratory partner suited to meet a broad range of testing needs.
NVIGEN is a nanobiotech built upon a proprietary Nanoparticle-Imaging-Delivery platform to enable biomedical breakthroughs with precisely tailorable nanoparticles for research, diagnostic and therapeutic applications. Website: http://www.nvigen.com/
Iverson Genetic Diagnostics is a genetics company focused on the next generation of healthcare. They oﬀer advanced genetic testing to health care providers to promote early disease detection and to help physicians achieve optimal dosing of critical medications.
The SCGPM was established in 2009 from within the department of Genetics at the Stanford Medical School. The SCGPM now involves more than 60 faculty from 13 departments with diverse research interests spanning basic science to clinical medicine.
WaferGen Biosystems is an innovative life science company offering genomic tools for targeted resequencing, genotyping and expression analysis. SmartChip TE™ is a target enrichment system geared towards clinical Next-Generation Sequencing (NGS). Clinical applications of targeted sequencing panels will benefit from improved accuracy and precision using SmartChip TE™. Based on singleplex PCR, the SmartChip TE™ system is characterized by superior coverage and coverage uniformity compared to multiplex approaches and by flexibility in panel design and optimization. Our SmartChip Real-Time PCR System is a next-generation genetic analysis platform for profiling and validating molecular biomarkers. It provides a range of high-throughput capabilities including microRNA, lncRNA and mRNA (gene expression) profiling as well as single nucleotide polymorphism (SNP) genotyping.
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.PersonalizedMedicineCoalition.org.
deClarity is a life sciences digital communications group that specializes in strategy, design, and production of 3-D animation, video, web, mobile, tablet and interactive applications. For 32 years we have helped life science companies tell powerful stories about their products and services that improve health. We focus on the science, technology and the people, never forgetting that the goal is to move the viewer to action. Using versatile digital tools, we execute whatever can be envisioned in promotional and educational content. Stop by to see our work and to talk with Diane Heditsian about your communications needs.
GeneCentric is a commercial stage start-up focused on delivering clinically meaningful diagnostics. Their first commercialized test (HistoPlusSM, LabCorp) is an mRNA signature for improved diagnosis of lung cancer subtypes. Website: www.genecentric.com
Oracle Health Sciences enables the convergence of the life sciences and healthcare industries with solutions that improve the quality of care, lower costs, and speed time to market. http://www.oracle.com/us/industries/health-sciences/overview/index.html
Cureline, Inc. is a global biospecimen management company that collaborates with major clinical and research centers in Europe, Asia, and the USA on human tissue acquisition projects. We collect, preserve and process a diverse range of human biospecimens for our clients including big pharma, biotech companies, medical devices and diagnostics companies, government and academic institutions. www.cureline.com
HealthTell, Inc. has developed a simple, accurate, and inexpensive test which can be performed with only a single drop of blood. This technology has already been demonstrated to work for over 30 diverse illnesses, ranging from cancer to infectious disease. Website: http://www.healthtell.com/
Assurex Health’s proprietary technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology. http://assurexhealth.com/
Ambry Genetics provides genetic services focused on clinical diagnostics and genomic services, particularly in sequencing and array services.
Fish & Richardson is an international law firm exclusively dedicated to intellectual property, litigation, and technology law. Founded in Boston in 1878, the firm has represented some of the greatest inventors of all time, including Alexander Graham Bell, Thomas Edison, and theWright brothers. Recognized as a world leader in intellectual property, the firm has 11 offices in the United States and one in Germany.
T2 Biosystems is developing a new class of clinical diagnostics powered by T2MR, the world’s first direct detection technology that delivers superior sensitivity at unmatched speed to guide more effective clinical decision-making. Website: www.t2biosystems.com
The Personalized Lifestyle Medicine Institute (PLMI) is a not-for-profit entity which cultivates virtual and in-person networks of collaboration between researchers, clinicians, patients, policy makers, and consumer advocates to bring personalized lifestyle medicine into greater visibility. http://plmitestsite.com/
Bina Technologies is pioneering a new approach to solving the big data challenges in Genomics and Personalized Medicine. Bina's combination of high-performance computing expertise combined with our proprietary statistical algorithms and optimized software provides dramatic improvements in the cost, accuracy, and speed of data analysis.
Bioneer’s mission is to become the preeminent solution provider in next-generation healthcare technologies such as oligonucleotide-based therapeutics, PCR diagnostics as well as drug screening tools. We will do this by applying our core competencies in molecular biology, DNA/RNA oligonucleotide synthesis chemistry, process development and instrument technology.
Integrated Genomics company providing sequencing experimental design consulting, sequence data analysis & interpretation, and education services to Healthcare, Agriculture and Bio-energy research.
The Bangalore, India based company offers a unique offshore bioinformatics services that serves as an augmented plug n play interdisciplinary team of resources from various discipline such as Statistics, Bioinformatics, Computational Biology, and Computing. At the centre of our services is iOMICSTM our proprietary software product designed to translate raw sequence data into meaningful biological insights which can be disseminated to scientists developing cutting-edge applications in disease research and management, corp management and energy management.
Nixon Peabody LLP is a full-service law firm that helps clients navigate complex challenges in litigation, real estate, corporate law, and finance.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is the largest and leading investment-grade real estate investment trust focused principally on owning, operating, and developing high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria pioneered the laboratory niche and has become the leading life science real estate brand in the top life science clusters.
Clusterk is a general purpose high-performance, cloud computing platform that allows the customer to save up to 90% and cut down on computing time. Website: N/A
Cypher Genomics provides knowledge through simultaneous utilization of information as well as analytical tools necessary to enable genomic interpretation and discovery.
Through its pioneering sequencing-as-a-service model, Complete Genomics provides the most accurate whole human genomes available today. The ease of use and power of Complete's advanced informatics and analysis systems provide genomic information needed to better understand the prevention, diagnosis, and treatment of diseases. Additional information can be found at http://www.completegenomics.com.
OMI is developing novel biomarkers based on clinical and genomic data and is using information generated from multiple sources to develop new treatments for neuro-immune and other diseases.
The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. http://www.crescendobio.com/
Trovagene is a molecular diagnostics company with innovative non-invasive cancer monitoring technology that detects and quantifies genetic alterations in tumors from cell-free DNA detectable in patients' urine using ultra-sensitive digital PCR and high-throughput next generation sequencing.
Trovagene molecular diagnostics improve cancer detection and monitoring. Able to isolate, extract and analyze cell-free nucleic acids from a simple urine sample, we enable near real-time detection of oncogene mutations for any tumor type. Trovagene develops novel cell-free diagnostics in blood and urine for clinically and therapeutically relevant genomic alterations. These innovative assays enable physicians to non-invasively assess tumor dynamics and tumor burden to more effectively monitor cancer patients before, during and after treatment.
Brain Resource, Inc. (BRRZY: OTC US, BRC: ASX) translates new findings about the brain into engaging products for consumers, employers and clinicians to improve cognition and brain function. With offices in San Francisco and Australia, and agents in Europe and Israel, the company is underpinned by an international consortium of scientists and clinicians that bring together all aspects about the brain that are usually assessed independently. For more information, follow Brain Resource on Twitter @MyBrainSolution or visit www.brainresource.com.
Endocyte is a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases. Endocyte uses its proprietary technology to create novel small molecule drug conjugates or SMDCs, and companion imaging agents. Endocyte’s SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone.
KPMG is a global network of professional firms providing Audit, Tax and Advisory services.
Natera is a leading genetic testing company that has developed a proprietary bioinformatics-based technology (NATUS) to deliver accurate and comprehensive high-throughput testing for reproductive indications from tiny amounts of DNA. Natera operates a CLIA-certified laboratory in San Carlos, CA, providing a host of preconception and prenatal genetic testing services.
Folio Biosciences is the leading provider of human tissue samples for research. Folio has the largest and most trusted human biospecimen repository – with over 2 million samples and up to 20 years of follow-up clinical data. Our collection has breadth and depth, and we also have custom procurement services, histopathology services, and a network of strategic partners to serve all of your needs.
Morrison Foerster, imagine lawyers who are as interested in what you do as you are. Who understand the value of your new technology or new product or new transaction. Who are prepared to work with you to create it, protect it and maximize your opportunity to derive value from it. Who'll help you to bring it to fruition, or finance it, or bring it to market, or sell it. And, who are prepared to zealously defend it – in or out of court. Imagine lawyers with imagination. This is MoFo.
TeselaGen is building a bioCAD/CAM rapid prototyping system for biology in order to provide a design-build-test-evolve platform for automated combinatorial DNA assembly, meeting customers’ needs for well-managed, scalable, and very low-cost DNA construction and assembly. Website: http://www.teselagen.com/
Big Science Media publishes Genome magazine (April 2014 launch), which covers the personalized medicine stories of today and the breakthroughs of tomorrow, so patients have the information they need to effectively manage their health. Personalized medicine is changing the way health care is delivered, but a crucial part of the process – patient education – is just beginning. Genome magazine acts as an information bridge, bringing relevant insight and knowledge to patients, family and caregivers, enabling people with chronic and life-altering diseases to live better, longer.
iNanoBio is developing a $1000 genome sequencer and pre-symptomatic disease diagnostics for personalized healthcare of the future. Website: http://www.inanobio.com/
GeneYouIn’s product platform PillCheck is a mobile application that seamlessly links your genetic data with FDA drug labels and provides personalized recommendations on drug use to reduce the risk of adverse side effects. Website: www.geneyouin.ca
Since 1999, Silicom Ventures has been a platform for investing in emerging technologies and producing large-scale, global conferences. For more information about Silicom Ventures, go to www.silicomventures.com
Hover over the booth # for more information